Influenza vaccines differentially regulate the interferon response in human dendritic cell subsets

Area of Science:

• Immunology
• Vaccinology
• Cell Biology

Background:

• Dendritic cells (DCs) are crucial for initiating adaptive immunity following influenza vaccination.
• Understanding early DC responses to vaccines is key to optimizing vaccine effectiveness.
• Nonadjuvanted monovalent H1N1 California vaccine (MIV-09) showed lower effectiveness than trivalent Fluzone 2009-2010 vaccine (TIV-09).

Purpose of the Study:

• To compare the early immune responses induced by MIV-09 and TIV-09 in human dendritic cell subsets.
• To investigate the role of interferon (IFN) production by DCs in vaccine efficacy.

Main Methods:

• Human monocyte-derived DCs (moDCs), conventional DCs (cDCs), and plasmacytoid DCs (pDCs) were exposed to MIV-09 and TIV-09.
• Expression of maturation markers (CD80, CD83, CD86) and secretion of cytokines and chemokines were measured.

Main Results:

• TIV-09 induced maturation markers and cytokine secretion, including type I IFNs (IFN-α, IFN-β) and IL-29, in moDCs and cDCs.
• MIV-09 failed to induce type I IFNs in moDCs and cDCs and even inhibited TIV-09-induced IFN secretion.
• Both vaccines stimulated pDCs to secrete type I IFNs, highlighting distinct DC subset activation pathways.

Conclusions:

• Nonadjuvanted influenza vaccines activate different molecular signaling pathways in distinct DC subsets.
• The ability of a vaccine to induce an IFN response in DCs may compensate for the lack of adjuvant, potentially increasing efficacy.